Roy Navon

5.4k total citations · 1 hit paper
20 papers, 3.2k citations indexed

About

Roy Navon is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Roy Navon has authored 20 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Epidemiology. Recurrent topics in Roy Navon's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Gene expression and cancer classification (5 papers). Roy Navon is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Gene expression and cancer classification (5 papers). Roy Navon collaborates with scholars based in Israel, United States and Switzerland. Roy Navon's co-authors include Zohar Yakhini, Israel Steinfeld, Eran Eden, Doron Lipson, Anya Tsalenko, Hui Wang, Amir Ben‐Dor, Anne‐Lise Børresen‐Dale, Olli Kallioniemi and Hilde Johnsen and has published in prestigious journals such as Nucleic Acids Research, Bioinformatics and PLoS ONE.

In The Last Decade

Roy Navon

18 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists

2009 2.4k citations Eran Eden, Roy Navon et al. BMC Bioinformatics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roy Navon Israel	10	2.1k	750	409	305	229	20	3.2k
Yuxing Liao United States	13	2.1k 1.0×	422 0.6×	386 0.9×	310 1.0×	312 1.4×	25	3.2k
Adam Ameur Sweden	32	2.4k 1.1×	485 0.6×	738 1.8×	234 0.8×	182 0.8×	96	3.7k
Oriol Fornés Canada	17	2.9k 1.4×	656 0.9×	540 1.3×	389 1.3×	221 1.0×	34	3.8k
Jeanne Chèneby France	8	2.2k 1.0×	549 0.7×	394 1.0×	323 1.1×	187 0.8×	10	3.0k
Sergi Sayols Germany	28	2.4k 1.1×	680 0.9×	539 1.3×	185 0.6×	241 1.1×	41	3.0k
Andreas Klingenhoff Germany	12	2.4k 1.1×	503 0.7×	513 1.3×	332 1.1×	254 1.1×	14	3.3k
Yan Zhou China	28	1.3k 0.6×	425 0.6×	332 0.8×	331 1.1×	191 0.8×	130	2.3k
Eric J. Jaehnig United States	11	1.4k 0.7×	426 0.6×	303 0.7×	253 0.8×	275 1.2×	20	2.3k
Marius Gheorghe Norway	9	2.0k 0.9×	487 0.6×	347 0.8×	295 1.0×	163 0.7×	12	2.6k
Sheng Zhong United States	34	3.4k 1.6×	602 0.8×	601 1.5×	175 0.6×	207 0.9×	98	4.3k

Countries citing papers authored by Roy Navon

Since Specialization

Citations

This map shows the geographic impact of Roy Navon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Navon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Navon more than expected).

Fields of papers citing papers by Roy Navon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Navon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Navon. The network helps show where Roy Navon may publish in the future.

Co-authorship network of co-authors of Roy Navon

This figure shows the co-authorship network connecting the top 25 collaborators of Roy Navon. A scholar is included among the top collaborators of Roy Navon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Navon. Roy Navon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lacroix, Laurence, Arnaud G. L’Huillier, Kristina Keitel, et al.. (2023). Host biomarkers and combinatorial scores for the detection of serious and invasive bacterial infection in pediatric patients with fever without source. PLoS ONE. 18(11). e0294032–e0294032. 9 indexed citations

Ashkenazi‐Hoffnung, Liat, Gilat Livni, Oded Scheuerman, et al.. (2021). Differential Serum and Urine CRP, IP-10, and TRAIL Levels in Pediatric Urinary Tract Infection. Frontiers in Pediatrics. 9. 771118–771118. 8 indexed citations

Gottlieb, Tanya, Isaac Srugo, Alain Gervaix, et al.. (2019). 2624. Viral Pneumonia in Children: Facing the Challenge Using the Host Response. Open Forum Infectious Diseases. 6(Supplement_2). S914–S914. 1 indexed citations

Ashkenazi‐Hoffnung, Liat, Kfir Oved, Roy Navon, et al.. (2018). A host-protein signature is superior to other biomarkers for differentiating between bacterial and viral disease in patients with respiratory infection and fever without source: a prospective observational study. European Journal of Clinical Microbiology & Infectious Diseases. 37(7). 1361–1371. 56 indexed citations

Shapira, Maanit, Olga Boico, Asi Cohen, et al.. (2018). Automating a New Host-Protein Assay for Differentiating Bacterial from Viral Infection to Reduce Operator Hands-On Time. BioTechniques. 65(2). 93–95.

Oved, Kfir, Eran Eden, Chantal B. van Houten, et al.. (2017). A Novel Host-protein Assay Accurately Distinguishes Bacterial From Viral Upper Respiratory Tract Infections. Open Forum Infectious Diseases. 4(suppl_1). S351–S352. 1 indexed citations

Oved, Kfir, Asi Cohen, Olga Boico, et al.. (2016). Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Protein as a Marker for Disease Severity in Patients With Acute Infection. Open Forum Infectious Diseases. 3(suppl_1).

Steinfeld, Israel, Roy Navon, Michael Creech, Zohar Yakhini, & Anya Tsalenko. (2015). ENViz: a Cytoscape App for integrated statistical analysis and visualization of sample-matched data with multiple data types. Bioinformatics. 31(10). 1683–1685. 10 indexed citations

Enerly, Espen, Israel Steinfeld, Kristine Kleivi Sahlberg, et al.. (2013). Correction: miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors. PLoS ONE. 8(9). 1 indexed citations

10.

Avraham, Roi, Aviv Barzilai, Roy Navon, et al.. (2012). Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor. Molecular Cancer. 11(1). 44–44. 114 indexed citations

11.

Steinfeld, Israel, Roy Navon, Robert A. Ach, & Zohar Yakhini. (2012). miRNA target enrichment analysis reveals directly active miRNAs in health and disease. Nucleic Acids Research. 41(3). e45–e45. 44 indexed citations

12.

Borgan, Eldrid, Roy Navon, Hans Kristian Moen Vollan, et al.. (2011). Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue. Molecular Oncology. 5(6). 564–576. 25 indexed citations

13.

Enerly, Espen, Israel Steinfeld, Kristine Kleivi Sahlberg, et al.. (2011). miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors. PLoS ONE. 6(2). e16915–e16915. 245 indexed citations

14.

Buganim, Yosef, Ido Goldstein, Doron Lipson, et al.. (2010). A Novel Translocation Breakpoint within the BPTF Gene Is Associated with a Pre-Malignant Phenotype. PLoS ONE. 5(3). e9657–e9657. 49 indexed citations

15.

Tiosano, Dov, Roy Navon, Carlos Knopf, et al.. (2010). A steroid metabolomic approach to 17α-hydroxylase/17,20 lyase deficiency. Metabolomics. 6(3). 417–426. 3 indexed citations

16.

Navon, Roy, Hui Wang, Israel Steinfeld, et al.. (2009). Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types. PLoS ONE. 4(11). e8003–e8003. 147 indexed citations

17.

Eden, Eran, Roy Navon, Israel Steinfeld, Doron Lipson, & Zohar Yakhini. (2009). GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics. 10(1). 48–48. 2429 indexed citations breakdown →

18.

Steinfeld, Israel, Roy Navon, Diego Ardigò, Ivana Zavaroni, & Zohar Yakhini. (2008). Clinically driven semi-supervised class discovery in gene expression data. Bioinformatics. 24(16). i90–i97. 15 indexed citations

19.

Steinfeld, Israel, Roy Navon, Diego Ardigò, Ivana Zavaroni, & Zohar Yakhini. (2007). Semi-supervised class discovery using quantitative phenotypes – CVD as a case study. BMC Bioinformatics. 8(S8). 4 indexed citations

20.

Frank, Graeme R. & Roy Navon. (1999). Growth Failure Associated with the Use of High Dose Prozac (Fluoxetine Hydrochloride) in a Patient with Type 1 Diabetes Mellitus. Journal of Pediatric Endocrinology and Metabolism. 12(3). 467–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact